XENE
Xenon Pharmaceuticals Inc. · Healthcare
Director Steven Gannon sold $641K of Xenon Pharmaceuticals Inc.
Sold$640,550
$64.06Price
10,000Shares
−84%Stake
What XENE did after the filing
- The stock from Fri, Aug 14 open, $63.60
- −41.4%
- S&P 500, same days
- −1.8%
Measured over 30 trading days, to the Sep 29 close.
Traded Tue, Aug 11. Filed Thu, Aug 13, 4:33 PM ET, after the close. Returns use the Aug 14 open and the Sep 29 close. Not investment advice.